cebranopadol (TRN-228) - Tris Pharma
THE EFFECTS OF CEBRANOPADOL ON VENTILATORY DRIVE, CENTRAL NERVOUS SYSTEM, AND PAIN (ASRA-SPRING 2025) - Apr 27, 2025 - Abstract #6651; Pres time: May 1, 2025; 01:30 PM - 03:30 PM; Location: Gatlin A3; "Taken together, the results of this and previous clinical studies, as well as results from preclinical models, provide evidence to support the likelihood a ceiling of respiratory depression exists in humans. However, these data lead us to conclude further studies are needed to fully characterize the ceiling of respiratory effects cebranopadol may exhibit." 
Addiction (Opioid and Alcohol) • CNS Disorders • Depression • Pain • Psychiatry
https://asraonline.egnyte.com/fl/KMTMGSvRyb
 
Simone Jansen; Antonio Pardo; Joseph Grieco; James Hackworth; Albert Dahan
 
Apr 27, 2025
 
Prev Next